Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00006496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Aug 2026 → Aug 2028
See other at-risk trials from Massachusetts General Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 2026 to Aug 2028
    • Study completion pushed from Dec 2026 to Dec 2028
    • Eligibility criteria expanded, about 6 words
    • Publications: details revised at 3 of 3 entries
  2. Primary completion date: Aug 2023 to Aug 2026
    • Study completion date: Dec 2023 to Dec 2026
    • Study title expanded, about 4 words
    v10
  3. Primary completion date: Aug 2022 to Aug 2023
    • Study completion date: Dec 2022 to Dec 2023
    v9
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v8
  5. Primary completion date: Aug 2019 to Aug 2022
    • Study completion date: Dec 2019 to Dec 2022
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Aug 2017 to Aug 2019
    • Study completion date: Dec 2017 to Dec 2019
    v6
  2. Primary completion date: Mar 2016 to Aug 2017
    • Study completion date: Mar 2016 to Dec 2017
    • Eligibility criteria expanded, about 65 words
    v5
  3. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI) to Massachusetts General Hospitalv4 Show 6 more changesShow less
    • Primary and study completion dates: Dec 2005 to Mar 2016
    • Trial status: Completed to Recruiting
    • Enrollment target: 4000
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 11 words
    • Collaborators expanded, about 7 words
  4. Trial status: Active, Not Recruiting to Completed
    • Primary completion date: Dec 2005
    v3
  5. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).
Trial Details
NCT Number NCT00006496
Lead Sponsor Massachusetts General Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions
(from sponsor)		 Acute Respiratory Distress Syndrome, Lung Diseases
Related terms Lung Diseases, Respiratory Distress Syndrome
Enrollment 4,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov